Compare Intuitive Surgical, Inc. (ISRG) vs Lucid Group Inc (LCID) Price & Performance

Intuitive Surgical (ISRG) trades at $350.06, down 1.34% on the day and near its 52-week low of $344.55. The stock is in a bearish technical trend despite strong fundamentals: Q2 2026 EPS beat estimates at $2.80 vs. $2.48 expected, revenue grew to $10.06B in 2025, and net income margin expanded to 28.45%. However, slowing U.S. procedure growth and a cautious 2026 outlook have pressured shares, with recent news highlighting a nearly 40% decline year-to-date.

The outlook remains mixed: robust profitability and a 69.6% analyst buy rating with a $504.56 consensus target suggest long-term value, but near-term risks include valuation concerns (P/E 40.5), competitive pressures, and macroeconomic headwinds. Investors face a divergence between solid execution and market sentiment driven by growth deceleration fears.

Lucid Group (LCID) trades at $7.32, down 0.54% on the day, with a bullish technical signal from moving averages but neutral oscillators. The company reported a net loss of $2.70 billion on $1.35 billion revenue in 2025, with negative profit margins and cash flow. Recent news highlights multiple class action lawsuits filed against the company, alleging securities fraud between February and April 2026.

The outlook remains challenged by persistent losses and high cash burn, though the consensus price target of $10.50 suggests potential upside. Key risks include ongoing litigation, competitive pressures in the EV market, and the need for additional financing to sustain operations amid negative cash flows.